High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids

Journal of Nutritional Biochemistry

Volumn 25, Issue 12, 2014, Pages 1263-1274

  Garcia Caraballo, Sonia C ^a   Comhair, Tine M ^a,c   Houten, Sander M ^b   Dejong, Cornelis H C ^a   Lamers, Wouter H ^a,b,c   Koehler, S Eleonore ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

Branched chain amino acids; Branched chain keto acids; Fatty acid composition; Fatty liver; High protein diet

Indexed keywords

BRANCHED CHAIN AMINO ACID; CHOLESTEROL; FATTY ACID; GLUCOSE; GLYCOGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOENOLPYRUVATE; PHOSPHOLIPID; TRIACYLGLYCEROL; 14-METHYLHEXADECANOIC ACID; FAT INTAKE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; GLUCAGON; GLUCOSE BLOOD LEVEL; INSULIN; LEPTIN; PALMITIC ACID DERIVATIVE; PPARGC1A PROTEIN, MOUSE; PROTEIN INTAKE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL LIVER LEVEL; CITRIC ACID CYCLE; CONTROLLED STUDY; FAT CONTENT; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; LIPID LIVER LEVEL; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN DIET; STEATOSIS; UPREGULATION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; FAT INTAKE; FATTY LIVER; GENETICS; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLISM; PROTEIN INTAKE; PROTEIN RESTRICTION; SEX DIFFERENCE;

MUS;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIET, HIGH-FAT; DIET, PROTEIN-RESTRICTED; DIETARY FATS; DIETARY PROTEINS; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCAGON; INSULIN; LEPTIN; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; PALMITIC ACIDS; PHOSPHOLIPIDS; SEX FACTORS; TRANSCRIPTION FACTORS; TRIGLYCERIDES; UP-REGULATION;

EID: 84922929938     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.07.005     Document Type: Article

References (75)

1. Brunt E.M. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010, 7:195-203.
2. Sunny N.E., Parks E.J., Browning J.D., Burgess S.C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 2011, 14:804-810.
3. Iozzo P., Bucci M., Roivainen A., Nagren K., Jarvisalo M.J., Kiss J., et al. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology 2010, 139:846-856. [56 e1-6].
4. Puri P., Baillie R.A., Wiest M.M., Mirshahi F., Choudhury J., Cheung O., et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46:1081-1090.
5. Satapati S., Sunny N.E., Kucejova B., Fu X., He T.T., Mendez-Lucas A., et al. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J Lipid Res 2012, 53:1080-1092.
6. Fabbrini E., Magkos F., Mohammed B.S., Pietka T., Abumrad N.A., Patterson B.W., et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 2009, 106:15430-15435.
7. Wobser H., Dorn C., Weiss T.S., Amann T., Bollheimer C., Buttner R., et al. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res 2009, 19:996-1005.
8. de Meijer V.E., Kalish B.T., Puder M., Ijzermans J.N. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 2010, 97:1331-1339.
9. Garcia-Caraballo S.C., Comhair T.M., Verheyen F., Gaemers I., Schaap F.G., Houten S.M., et al. Prevention and reversal of hepatic steatosis with a high-protein diet in mice. Biochim Biophys Acta 1832, 2013:685-695.
10. Bortolotti M., Maiolo E., Corazza M., Van Dijke E., Schneiter P., Boss A., et al. Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients. Clin Nutr 2011, 30:494-498.
11. Rémésy C., Demigné C., Aufrère J. inter-organ relationships betwee glucose, lactate and amino acids in rats fed on high-carbohydrate or high-protein diets. Biochem J 1978, 170:321-329.
12. Moundras C., Remesy C., Demigne C. Dietary protein paradox: decrease of amino acid availability induced by high-protein diets. Am J Physiol 1993, 264:G1057-G1065.
13. Morens C., Gaudichon C., Fromentin G., Marsset-Baglieri A., Bensaid A., Larue-Achagiotis C., et al. Daily delivery of dietary nitrogen to the periphery is stable in rats adapted to increased protein intake. Am J Physiol Endocrinol Metab 2001, 281:E826-E836.
14. Robinson J.L., Foustock S., Chanez M., Bois-Joyeux B., Peret J. Circadian variation of liver metabolites and amino acids in rats adapted to a high protein, carbohydrate-free diet. J Nutr 1981, 111:1711-1720.
15. Kniazeva M., Euler T., Han M. A branched-chain fatty acid is involved in post-embryonic growth control in parallel to the insulin receptor pathway and its biosynthesis is feedback-regulated in C. elegans. Genes Dev 2008, 22:2102-2110.
16. Seyama Y., Uchijima Y. Novel function of lipids as a pheromone from the Harderian gland of golden hamster. Proc Jpn Acad Ser B Phys Biol Sci 2007, 83:77-96.
17. Obayashi M., Shimomura Y., Nakai N., Jeoung N.H., Nagasaki M., Murakami T., et al. Estrogen controls branched-chain amino acid catabolism in female rats. J Nutr 2004, 134:2628-2633.
18. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
19. van Eijk H.M., Rooyakkers D.R., Deutz N.E. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column. J Chromatogr 1993, 620:143-148.
20. Roehrig K.L., Allred J.B. Direct enzymatic procedure for the determination of liver glycogen. Anal Biochem 1974, 58:414-421.
21. Dacremont G., Vincent G. Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J Inherit Metab Dis 1995, 18(Suppl 1):84-89.
22. MacKay E.M., Bergman H.C. The relation between glycogen and water storage in the liver. J Biol Chem 1932, 96:373-380.
23. Kotronen A., Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
24. Kotronen A., Seppanen-Laakso T., Westerbacka J., Kiviluoto T., Arola J., Ruskeepaa A.L., et al. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 2009, 58:203-208.
25. Hudgins L.C., Hellerstein M., Seidman C., Neese R., Diakun J., Hirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest 1996, 97:2081-2091.
26. Jump D.B. Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care 2011, 14:115-120.
27. Suryawan A., Hawes J.W., Harris R.A., Shimomura Y., Jenkins A.E., Hutson S.M. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 1998, 68:72-81.
28. Musso G., Gambino R., Cassader M., Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 2010, 52:79-104.
29. Lam B.P., Younossi Z.M. Treatment regimens for non-alcoholic fatty liver disease. Ann Hepatol 2009, 8(Suppl 1):S51-S59.
30. Cao J.J., Nielsen F.H. Acid diet (high-meat protein) effects on calcium metabolism and bone health. Curr Opin Clin Nutr Metab Care 2010, 13:698-702.
31. Darling A.L., Millward D.J., Torgerson D.J., Hewitt C.E., Lanham-New S.A. Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr 2009, 90:1674-1692.
32. Brinkworth G.D., Buckley J.D., Noakes M., Clifton P.M. Renal function following long-term weight loss in individuals with abdominal obesity on a very-low-carbohydrate diet vs high-carbohydrate diet. J Am Diet Assoc 2010, 110:633-638.
33. Gannon M.C., Nuttall F.Q. Amino acid ingestion and glucose metabolism - a review. IUBMB Life 2010, 62:660-668.
34. Freudenberg A., Petzke K.J., Klaus S. Comparison of high-protein diets and leucine supplementation in the prevention of metabolic syndrome and related disorders in mice. J Nutr Biochem 2012, 23:1524-1530.
35. Bortolotti M., Kreis R., Debard C., Cariou B., Faeh D., Chetiveaux M., et al. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr 2009, 90:1002-1010.
36. Boulange C.L., Claus S.P., Chou C.J., Collino S., Montoliu I., Kochhar S., et al. Early metabolic adaptation in C57BL/6 mice resistant to high fat diet induced weight gain involves an activation of mitochondrial oxidative pathways. J Proteome Res 2013, 12(4):1956-1968.
37. Duval C., Thissen U., Keshtkar S., Accart B., Stienstra R., Boekschoten M.V., et al. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. Diabetes 2010, 59:3181-3191.
38. Comhair T.M., Garcia Caraballo S.C., Dejong C.H.C., Lamers W.H., Koehler S.E. Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat. Nutr Metab (Lond) 2011, 8:4.
39. de Wit N., Derrien M., Bosch-Vermeulen H., Oosterink E., Keshtkar S., Duval C., et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol 2012, 303:G589-G599.
40. Neuschwander-Tetri B.A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010, 52:774-788.
41. Westerterp-Plantenga M.S., Lejeune M.P.G.M., Smeets A.J.P.G., Luscombe-Marsh N.D. Sex differences in energy homeostatis following a diet relatively high in protein exchanged with carbohydrate, assessed in a respiration chamber in humans. Physiol Behav 2009, 97:414-419.
42. Cortright R.N., Koves T.R. Sex differences in substrate metabolism and energy homeostasis. Can J Appl Physiol 2000, 25:288-311.
43. Waxman D.J., O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 2006, 20:2613-2629.
44. Gustavsson C., Yassin K., Wahlstrom E., Cheung L., Lindberg J., Brismar K., et al. Sex-different hepaticglycogen content and glucose output in rats. BMC Biochem 2010, 11:38.
45. De Marinis E., Martini C., Trentalance A., Pallottini V. Sex differences in hepatic regulation of cholesterol homeostasis. J Endocrinol 2008, 198:635-643.
46. Ikejima K., Enomoto N., Iimuro Y., Ikejima A., Fang D., Xu J., et al. Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol 1998, 274:G669-G676.
47. MacLeod J.N., Pampori N.A., Shapiro B.H. Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J Endocrinol 1991, 131:395-399.
48. Noguchi Y., Nishikata N., Shikata N., Kimura Y., Aleman J.O., Young J.D., et al. Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice. PLoS One 2010, 5:e12057.
49. Stepien M., Gaudichon C., Fromentin G., Even P., Tome D., Azzout-Marniche D. Increasing protein at the expense of carbohydrate in the diet down-regulates glucose utilization as glucose sparing effect in rats. PLoS One 2011, 6:e14664.
50. Miyazaki M., Dobrzyn A., Sampath H., Lee S.H., Man W.C., Chu K., et al. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J Biol Chem 2004, 279:35017-35024.
51. Raymond F., Wang L., Moser M., Metairon S., Mansourian R., Zwahlen M.C., et al. Consequences of exchanging carbohydrates for proteins in the cholesterol metabolism of mice fed a high-fat diet. PLoS One 2012, 7:e49058.
52. Ferre P., Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 2010, 12(Suppl 2):83-92.
53. Ye J.M., Doyle P.J., Iglesias M.A., Watson D.G., Cooney G.J., Kraegen E.W. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 2001, 50:411-417.
54. Kim H., Haluzik M., Asghar Z., Yau D., Joseph J.W., Fernandez A.M., et al. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes 2003, 52:1770-1778.
55. Carmona M.C., Louche K., Nibbelink M., Prunet B., Bross A., Desbazeille M., et al. Fenofibrate prevents rosiglitazone-induced body weight gain in ob/ob mice. Int J Obes (Lond) 2005, 29:864-871.
56. Bender D.A. The metabolism of "surplus" amino acids. Br J Nutr 2012, 108(Suppl 2):S113-S121.
57. Azzout-Marniche D., Gaudichon C., Blouet C., Bos C., Mathe V., Huneau J.F., et al. Liver glyconeogenesis: a pathway to cope with postprandial amino acid excess in high-protein fed rats?. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1400-R1407.
58. Veldhorst M.A., Westerterp-Plantenga M.S., Westerterp K.R. Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet. Am J Clin Nutr 2009, 90:519-526.
59. Li H., Fang Q., Gao F., Fan J., Zhou J., Wang X., et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 2010, 53:934-940.
60. Fisher F.M., Chui P.C., Antonellis P.J., Bina H.A., Kharitonenkov A., Flier J.S., et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010, 59:2781-2789.
61. Bielohuby M., Menhofer D., Kirchner H., Stoehr B.J., Muller T.D., Stock P., et al. Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein. Am J Physiol Endocrinol Metab 2011, 300:E65-E76.
62. Schaap F.G., Kremer A.E., Lamers W.H., Jansen P.L., Gaemers I.C. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress. Biochimie 2013, 95:692-699.
63. Dang Do A.N., Kimball S.R., Cavener D.R., Jefferson L.S. eIF2alpha kinases GCN2 and PERK modulate transcription and translation of distinct sets of mRNAs in mouse liver. Physiol Genomics 2009, 38:328-341.
64. De Sousa-Coelho A.L., Marrero P.F., Haro D. Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation. Biochem J 2012, 443:165-171.
65. Rakhshandehroo M., Stienstra R., de Wit N.J., Bragt M.C., Haluzik M., Mensink R.P., et al. Plasma mannose-binding lectin is stimulated by PPARalpha in humans. Am J Physiol Endocrinol Metab 2012, 302:E595-E602.
66. Potthoff M.J., Inagaki T., Satapati S., Ding X., He T., Goetz R., et al. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A 2009, 106:10853-10858.
67. Xu J., Lloyd D.J., Hale C., Stanislaus S., Chen M., Sivits G., et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 2009, 58:250-259.
68. Oku H., Mimura K., Tokitsu Y., Onaga K., Iwasaki H., Chinen I. Biased distribution of the branched-chain fatty acids in ceramides of vernix caseosa. Lipids 2000, 35:373-381.
69. Zhu H., Shen H., Sewell A.K., Kniazeva M., Han M. A novel sphingolipid-TORC1 pathway critically promotes postembryonic development in Caenorhabditis elegans. Elife 2013, 2:e00429.
70. Oku H., Yagi N., Nagata J., Chinen I. Precursor role of branched-chain amino acids in the biosynthesis of iso and anteiso fatty acids in rat skin. Biochim Biophys Acta 1994, 1214:279-287.
71. Borsheim E., Bui Q.U., Tissier S., Cree M.G., Ronsen O., Morio B., et al. Amino acid supplementation decreases plasma and liver triacylglycerols in elderly. Nutrition 2009, 25:281-288.
72. Nishimura J., Masaki T., Arakawa M., Seike M., Yoshimatsu H. Isoleucine prevents the accumulation of tissue triglycerides and upregulates the expression of PPARalpha and uncoupling protein in diet-induced obese mice. J Nutr 2010, 140:496-500.
73. Wahle K.W., Hare W.R. The effect of dietary methyl branched-chain fatty acids on aspects of hepatic lipid metabolism in the rat. Br J Nutr 1982, 47:61-67.
74. Brooks K.K., Liang B., Watts J.L. The influence of bacterial diet on fat storage in C. elegans. PLoS One 2009, 4:e7545.
75. Zhang H., Kim A., Abraham N., Khan L.A., Gobel V. Vesicular sorting controls the polarity of expanding membranes in the C. elegans intestine. Worm 2013, 2:e23702.